Logo image of CNNE

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

USA - NYSE:CNNE - US13765N1072 - Common Stock

18.49 USD
+0.13 (+0.71%)
Last: 10/23/2025, 4:15:00 PM
18.49 USD
0 (0%)
After Hours: 10/23/2025, 4:15:00 PM
Fundamental Rating

3

Taking everything into account, CNNE scores 3 out of 10 in our fundamental rating. CNNE was compared to 99 industry peers in the Financial Services industry. While CNNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CNNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CNNE has reported negative net income.
In the past year CNNE has reported a negative cash flow from operations.
CNNE had negative earnings in 4 of the past 5 years.
In the past 5 years CNNE always reported negative operating cash flow.
CNNE Yearly Net Income VS EBIT VS OCF VS FCFCNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

CNNE has a worse Return On Assets (-23.04%) than 89.90% of its industry peers.
The Return On Equity of CNNE (-29.79%) is worse than 86.87% of its industry peers.
Industry RankSector Rank
ROA -23.04%
ROE -29.79%
ROIC N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
CNNE Yearly ROA, ROE, ROICCNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

CNNE has a worse Gross Margin (16.13%) than 64.65% of its industry peers.
In the last couple of years the Gross Margin of CNNE has grown nicely.
CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
CNNE Yearly Profit, Operating, Gross MarginsCNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

6

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNNE has been reduced compared to 1 year ago.
CNNE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CNNE is higher compared to a year ago.
CNNE Yearly Shares OutstandingCNNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CNNE Yearly Total Debt VS Total AssetsCNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 1.97 indicates that CNNE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.97, CNNE is in the better half of the industry, outperforming 76.77% of the companies in the same industry.
CNNE has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.04, CNNE belongs to the best of the industry, outperforming 83.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC7.99%
CNNE Yearly LT Debt VS Equity VS FCFCNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CNNE has a Current Ratio of 2.78. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
CNNE's Current ratio of 2.78 is amongst the best of the industry. CNNE outperforms 80.81% of its industry peers.
CNNE has a Quick Ratio of 2.78. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.78, CNNE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 2.78
CNNE Yearly Current Assets VS Current LiabilitesCNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.03% over the past year.
Looking at the last year, CNNE shows a very negative growth in Revenue. The Revenue has decreased by -11.07% in the last year.
CNNE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.81% yearly.
EPS 1Y (TTM)1.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.83%
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.61%

3.2 Future

Based on estimates for the next years, CNNE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.25% on average per year.
CNNE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.75% yearly.
EPS Next Y-38.95%
EPS Next 2Y30.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-3.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNNE Yearly Revenue VS EstimatesCNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CNNE Yearly EPS VS EstimatesCNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNNE. In the last year negative earnings were reported.
Also next year CNNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNNE Price Earnings VS Forward Price EarningsCNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNNE Per share dataCNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 30.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.25%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 2.81%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.15, CNNE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, CNNE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

CNNE has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNNE Yearly Dividends per shareCNNE Yearly Dividends per shareYearly Dividends per share 2021 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

CNNE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-7.36%
EPS Next 2Y30.25%
EPS Next 3YN/A
CNNE Yearly Income VS Free CF VS DividendCNNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

CANNAE HOLDINGS INC

NYSE:CNNE (10/23/2025, 4:15:00 PM)

After market: 18.49 0 (0%)

18.49

+0.13 (+0.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners95.55%
Inst Owner Change0.04%
Ins Owners11.57%
Ins Owner Change0.17%
Market Cap1.04B
Revenue(TTM)437.20M
Net Income(TTM)-411500000
Analysts85
Price Target22.44 (21.36%)
Short Float %8.54%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-7.36%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-16 2025-09-16 (0.15)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-820.52%
Min EPS beat(2)-1301.07%
Max EPS beat(2)-339.96%
EPS beat(4)1
Avg EPS beat(4)-446.98%
Min EPS beat(4)-1301.07%
Max EPS beat(4)0.45%
EPS beat(8)1
Avg EPS beat(8)-537.2%
EPS beat(12)3
Avg EPS beat(12)-359.08%
EPS beat(16)3
Avg EPS beat(16)-2527.74%
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-3.92%
Max Revenue beat(2)-1.74%
Revenue beat(4)2
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.92%
Max Revenue beat(4)5.68%
Revenue beat(8)3
Avg Revenue beat(8)-3.75%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)3
Avg Revenue beat(16)-6.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.51%
EPS NY rev (1m)-44.33%
EPS NY rev (3m)-140.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.37
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.79
EV/EBITDA N/A
EPS(TTM)-6.7
EYN/A
EPS(NY)-1.43
Fwd EYN/A
FCF(TTM)-1.15
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS7.81
BVpS24.66
TBVpS23.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.04%
ROE -29.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.13%
FCFM N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
F-Score5
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.99%
Cap/Sales 1.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 2.78
Altman-Z 1.97
F-Score5
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)55.99%
Cap/Depr(5y)58.5%
Cap/Sales(3y)1.82%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.83%
EPS Next Y-38.95%
EPS Next 2Y30.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.61%
Revenue Next Year-5.69%
Revenue Next 2Y-3.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-59.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.14%
OCF growth 3YN/A
OCF growth 5YN/A